Summary:
A Russian company from Nizhny Novgorod is engaged in the production of a medical exoskeleton designed for the rehabilitation of patients after temporary loss of mobility of the lower extremities. The company is looking for foreign partners to conclude a long-term distribution services or commercial agency agreement.
Description:
The Russian company from Nizhny Novgorod is engaged in the development and production of medical equipment. The company produces equipment for medical rehabilitation, including high-tech complexes with biofeedback, devices for local and system-wide physiotherapy and mud treatment products. The company has its own production areas of over 3000 m / sq. Recently, new equipment with numerical software has been purchased and launched.
This medical exoskeleton is designed for the rehabilitation of patients after a temporary loss of mobility of the lower extremities, as well as for permanent use by people with complete loss of functionality of the lower extremities. The exoskeleton is designed to take into account modern trends in medical rehabilitation, assistive technologies and the adaptation of the complex to the anthropometric parameters of the patient.
Technical features of this medical exoskeleton: Built-in battery, assembled from high-current lithium-iron-phosphate cells; Gear motors with increased safety margin; Built-in microcomputer, which stores the patient database and collects statistics for each patient; Withstands patient weight up to 110, height 150-190; up to 8 hours of battery life.
To date, a positive experience has been obtained in the rehabilitation of patients with the consequences of stroke when using an exoskeleton. Exo rehabilitation also helps patients after a traumatic brain injury with motor disorders, with traumatic spinal cord disease, with a pathological walking pattern in diseases of the musculoskeletal system, etc.
The medical exoskeleton demonstrates the possibility of activating neuroplasticity processes in patients with impaired balance and walking due to increased afferent flow from paretic limbs. To achieve adequate and continuous afferent support, you can use regular, long-term and targeted training.
The Russian company has also developed several versions of the exoskeleton. There is an individual version for permanent home use by one patient with a limited value of adjustments, made for a specific patient, and also a rehabilitation version for hospitals with a simple and quick way to adjust to the patient. The developed exoskeleton has ISO certification, and also plans to receive additional certificates.
The Russian company is interested in finding partners from the medical field to conclude distribution services or commercial agency agreement. In accordance with the agreement on distribution services, the Russian company will supply the rehabilitation exoskeleton to the partner for its further distribution on the international market. The company will attach all the necessary documentation and technical guidance.
As a result of entering into a commercial agency agreement, the company is interested in working with agents and wholesalers who seek to increase their portfolio of medical rehabilitation products. More precise terms will be discussed personally with the potential partner.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
Type: SMEs, large companies, medical centers, rehabilitation clinics.
Role:
In accordance with a distribution services agreement: the potential partner will be engaged in the distribution of the rehabilitation exoskeleton in their market.
In accordance with a commercial agency agreement: a potential partner is ready to act as an agent representing a Russian product on their market.
Stage of Development:
Already on the market
IPR Status:
Secret Know-how
External code:
BORU20210414001